Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical resting-state connectivity in migraine patients. Szabo E, Bolo NR, Borsook D, Burstein R, et al. Cephalalgia 2025;45:3331024241313377.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Szabo E, Bolo NR, Borsook D, Burstein R, et al. Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical resting-state connectivity in migraine patients. Cephalalgia 2025;45:3331024241313377.
PMID: 39995155